Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population

Inflammation seems to play a critical role in the development of many types of cancer, including gastric, colorectal, and bladder cancers ([1][1]-[6][2]). The presence of chronic inflammation has been well described in gastric cancer, the fourth most common cancer diagnosis and second most common

[1]  Bernice R. Packer,et al.  High level of functional polymorphism indicates a unique role of natural selection at human immune system loci , 2005, Immunogenetics.

[2]  R. Millikan,et al.  Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  T. Koike,et al.  The polymorphism interleukin 8 −251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population , 2005, Gut.

[4]  J. Ferlay,et al.  Cancer incidence and mortality in Europe, 2004. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  S. Crowe.  Helicobacter infection, chronic inflammation, and the development of malignancy , 2005, Current opinion in gastroenterology.

[6]  Peter Boyle,et al.  Cancer incidence and mortality in Europe , 2005, Sozial- und Präventivmedizin.

[7]  S. Chanock,et al.  Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  G. Weverling,et al.  An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi's sarcoma: a case–control study , 2004, AIDS.

[9]  Vidar Skaug,et al.  Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. , 2003, Carcinogenesis.

[10]  Brian Staats,et al.  SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes , 2004, Nucleic Acids Res..

[11]  J. Sung,et al.  Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. , 2003, Gut.

[12]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[13]  P. Munkholm.  Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.

[14]  N. Laird,et al.  Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.

[15]  Stefano Landi,et al.  Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. , 2003, Cancer research.

[16]  Chien-Jen Chen,et al.  Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese , 2003, International journal of cancer.

[17]  R. Eeles,et al.  Influence of cytokine gene polymorphisms on the development of prostate cancer. , 2002, Cancer research.

[18]  M. Gammon,et al.  The epidemiology of gastric cancer. , 2002, Seminars in radiation oncology.

[19]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[20]  K. Chayama,et al.  Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas? , 2001, European journal of cancer.

[21]  M. Carrington,et al.  correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer , 2001, Nature.

[22]  D. Graham,et al.  Relation between Cytokines and Helicobacter pylori in Gastric Cancer , 2001, Helicobacter.

[23]  L. Coussens,et al.  Inflammatory Cells and Cancer , 2001, The Journal of experimental medicine.

[24]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[25]  E. Martinelli,et al.  Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[26]  D. Kwiatkowski,et al.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families , 2000, Thorax.

[27]  I. Fidler,et al.  Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[29]  J. Steffen.  The role of interleukin-1 polymorphism in the pathogenesis of gastric cancer , 2000 .

[30]  C. Stadtländer,et al.  Molecular epidemiology, pathogenesis and prevention of gastric cancer. , 1999, Carcinogenesis.

[31]  L. Sobin,et al.  Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland , 1999 .

[32]  P. Ernst,et al.  Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.

[33]  F W MULSOW,et al.  Cancer incidence and mortality , 2019, Health at a Glance: Europe.